TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 22,670 | $75,000 | 0.06% |
| Wealthspire Advisors, L.P. | 11,708 | $39,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 1,091 | $4,000 | 0.01% |
| Blume Capital Management, Inc. | 2,546 | $8,000 | 0.01% |
| Westside Investment Management, Inc. | 2,862 | $9,159,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 22,000 | $73,000 | 0.00% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $6,000 | 0.00% |
| STRS OHIO | 107,400 | $354,000 | 0.00% |
| Parallax Volatility Advisers, L.P. | 80,000 | $264,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,946 | $13,000 | 0.00% |